RELX PLC $RELX Shares Sold by Earnest Partners LLC

Key Points

• Earnest Partners LLC reduced its position in Relx Plc by 11.4%, owning 61,715 shares worth approximately $3.1 million as per their latest SEC filing.
• Relx has declared a semi-annual dividend of $0.2634 per share, which will be paid on September 16th, reflecting a yield of 170.0%.
• Analysts recently upgraded Relx's stock rating from "hold" to "buy," with a consensus rating of "Buy" across multiple investment analysts.

Earnest Partners LLC lessened its stake in shares of RELX PLC (NYSE:RELX - Free Report) by 11.4% in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 61,715 shares of the technology company's stock after selling 7,940 shares during the quarter. Earnest Partners LLC's holdings in RELX were worth $3,111,000 as of its most recent SEC filing.

Other hedge funds also recently bought and sold shares of the company. ABC Arbitrage SA boosted its stake in RELX by 40.1% during the first quarter. ABC Arbitrage SA now owns 194,197 shares of the technology company's stock worth $9,789,000 after buying an additional 55,579 shares during the period. Charles Schwab Investment Management Inc. boosted its stake in shares of RELX by 16.5% in the first quarter. Charles Schwab Investment Management Inc. now owns 167,175 shares of the technology company's stock valued at $8,427,000 after purchasing an additional 23,692 shares during the period. Pandora Wealth Inc. purchased a new position in shares of RELX in the first quarter valued at approximately $757,000. Massachusetts Financial Services Co. MA boosted its stake in shares of RELX by 103.7% in the first quarter. Massachusetts Financial Services Co. MA now owns 106,220 shares of the technology company's stock valued at $5,355,000 after purchasing an additional 54,062 shares during the period. Finally, Cambridge Investment Research Advisors Inc. boosted its stake in shares of RELX by 19.5% in the first quarter. Cambridge Investment Research Advisors Inc. now owns 18,957 shares of the technology company's stock valued at $956,000 after purchasing an additional 3,092 shares during the period. Hedge funds and other institutional investors own 15.02% of the company's stock.

Wall Street Analysts Forecast Growth

Separately, Wall Street Zen raised shares of RELX from a "hold" rating to a "buy" rating in a research note on Saturday, July 26th. One equities research analyst has rated the stock with a Strong Buy rating and four have given a Buy rating to the company. According to MarketBeat.com, the company has a consensus rating of "Buy".

RELX Stock Down 0.7%

Shares of RELX stock traded down $0.32 during trading on Friday, hitting $46.64. 1,853,527 shares of the stock were exchanged, compared to its average volume of 1,616,113. The stock has a market cap of $85.56 billion, a price-to-earnings ratio of 25.08, a price-to-earnings-growth ratio of 3.04 and a beta of 0.87. The firm's 50-day moving average price is $51.18 and its 200 day moving average price is $51.37. RELX PLC has a 12-month low of $44.19 and a 12-month high of $56.33. The company has a debt-to-equity ratio of 2.55, a current ratio of 0.47 and a quick ratio of 0.42.

RELX Cuts Dividend

The company also recently disclosed a semi-annual dividend, which will be paid on Tuesday, September 16th. Stockholders of record on Friday, August 8th will be given a dividend of $0.2634 per share. This represents a dividend yield of 170.0%. The ex-dividend date of this dividend is Friday, August 8th. RELX's payout ratio is 28.49%.

RELX Company Profile

RELX Plc engages in provision of information and analytics solutions for professional and business customers across industries. It operates through the following business segments: Scientific, Technical & Medical; Risk & Business Analytics; Legal; and Exhibitions. The Scientific, Technical & Medical segment is a global information analytics business that helps institutions and professionals advance healthcare, open science, and improve performance for the benefit of humanity.